Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
2
×
clinical trials
life sciences
national blog main
national top stories
new york blog main
acorda therapeutics
allergan
amgen
ampyra
apokyn
apomorphine
biohaven
biotech
boston blog main
boston top stories
cgpr
dalfampridine
duopa
eli lilly
europe blog main
fda
inbrija
merck
migraine
mylan
national
new york
new york top stories
parkinson's disease
paul matteis
stiel
sunovion pharmaceuticals
What
approved
fda
new
nod
2
×
treatment
acorda
adults
allergan
class
cope
disease
drug
episodes
friday
gets
help
late
looms
meant
medications
medicines
migraine
monday
parkinson’s
patients
pill
rival
stop
treat
ubrelvy
ubrogepant
wins
working
Language
unset
Current search:
abbvie
×
nod
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms